RWM
VRTX icon

Ritholtz Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Ritholtz Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
4,850
+438
+10% +$204K 0.04% 357
2025
Q4 		$2M Buy
4,412
+759
+21% +$327K 0.04% 349
2025
Q3 		$1.43M Sell
3,653
-9
-0.2% -$3.76K 0.03% 416
2025
Q2 		$1.63M Buy
3,662
+203
+6% +$93.5K 0.04% 347
2025
Q1 		$1.68M Buy
3,459
+430
+14% +$200K 0.05% 283
2024
Q4 		$1.22M Sell
3,029
-16
-0.5% -$7.42K 0.04% 320
2024
Q3 		$1.42M Buy
3,045
+217
+8% +$104K 0.04% 297
2024
Q2 		$1.33M Buy
2,828
+572
+25% +$248K 0.04% 278
2024
Q1 		$943K Buy
2,256
+362
+19% +$153K 0.03% 375
2023
Q4 		$771K Buy
1,894
+264
+16% +$97.5K 0.03% 387
2023
Q3 		$567K Sell
1,630
-1
-0.1% -$350 0.03% 427
2023
Q2 		$574K Buy
1,631
+93
+6% +$31.3K 0.03% 402
2023
Q1 		$485K Sell
1,538
-37
-2% -$11.1K 0.02% 413
2022
Q4 		$455K Sell
1,575
-1,190
-43% -$363K 0.03% 382
2022
Q3 		$801K Buy
2,765
+1,894
+217% +$545K 0.04% 295
2022
Q2 		$245K Buy
+871
New +$233K 0.02% 456

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ritholtz Wealth Management's VRTX Position: Q1 2026 in Review

Ritholtz Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q1 2026, buying an estimated $204K and bringing the position to 4,850 shares worth $2.17M. The position accounts for 0.04% of the portfolio, ranked #357.

Ritholtz Wealth Management first reported a position in VRTX in Q2 2022 and has held it in 16 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Ritholtz Wealth Management held 4,850 shares of Vertex Pharmaceuticals worth $2.17M as of Q1 2026.
  • Ritholtz Wealth Management bought 438 Vertex Pharmaceuticals shares in Q1 2026, an estimated $204K.
  • Vertex Pharmaceuticals made up 0.04% of Ritholtz Wealth Management's portfolio in Q1 2026, its #357 holding.
  • Ritholtz Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.